-

Agilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) today announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatography/mass spectrometry (GC/MS) column technology. Agilent has a 50-year history of innovation in gas chromatography, continually setting the standard for GC column performance. The new Agilent J&W 5Q GC/MS columns combine Agilent’s industry-recognized ultra-inert performance and ultra-low-bleed technology, delivering unmatched performance and durability for the most demanding applications.

In modern gas chromatography/mass spectrometry (GC/MS) workflows, GC/MS columns are often subjected to complex matrices and chemically active analytes that require reporting at trace levels. Under these conditions, maintaining the data quality needed to meet regulatory targets or other analytical requirements necessitates more frequent column changes, source cleaning, and potential sample re-runs, which decreases laboratory efficiency and increases costs.

Agilent J&W GC/MS 5Q columns provide exceptional peak symmetry for active analytes and set a new industry standard for minimal column bleed, enabling high sensitivity, maintaining accuracy and mass spectral fidelity, and accurate quantitation for the most challenging trace-level analytes. Additionally, these new GC/MS columns feature faster conditioning and are especially resistant to conditions that can shorten column life. Agilent J&W GC/MS 5Q columns enhance system performance in particularly difficult conditions, such as the use of hydrogen as a carrier gas, and in environmental workflows targeting emerging analytes of interest, where exceptional sensitivity and column durability are critical.

“This launch marks one of our most significant advancements in GC/MS column technology. The new J&W 5Q GC/MS columns are engineered to meet the rigorous demands of modern analytical laboratories,” said David Edwards, vice president and general manager of Agilent’s Chemistries Division. “By reducing the frequency of column changes and enhancing system performance, these columns not only improve data quality but also significantly boost laboratory efficiency and reduce operational costs.”

“Eagerly anticipated by our customers, this GC/MS column innovation underscores Agilent’s commitment to providing cutting-edge solutions that empower scientists to achieve their analytical goals with greater ease and reliability,” Edwards added.

Available in a range of dimensions, the Agilent J&W 5Q GC/MS columns extend the analytical options available to labs across a wide sector of markets and applications, including PFAS testing in environmental samples, analysis of residual pesticides in food, and more. Their enhanced performance strengthens Agilent’s position as a premium provider of solutions that push the boundaries of analytical methodology, allowing users of industry-leading Agilent GC/MS systems to extract even greater performance and value from their instruments.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Contacts

MEDIA CONTACT
Naomi Goumillout
Agilent Technologies
+1.978.314.1862
naomi.goumillout@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

MEDIA CONTACT
Naomi Goumillout
Agilent Technologies
+1.978.314.1862
naomi.goumillout@agilent.com

More News From Agilent Technologies Inc.

Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today reported revenue of $1.86 billion for the fourth quarter ended October 31, 2025, exceeding revenue guidance and representing growth of 9.4% reported and up 7.2% core(1) compared with the fourth quarter of 2024. Fourth-quarter GAAP net income was $434 million, or $1.53 per share. This compares with $351 million, or $1.22 per share, in the fourth quarter of 2024. Non-GAAP(2) net income was $452 million, or $1.59 per...

Agilent Announces Cash Dividend of 25.5 Cents Per Share

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on Jan. 28, 2026, to all shareholders of record as of the close of business on Jan. 6, 2026. The timing and amounts of future dividends are subject to the determination and approval by Agilent’s board of directors. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in analytical...

Agilent to Participate in Citi’s 2025 Global Healthcare Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Chief Enterprise Transformation Officer Tom Callihan and Head of Investor Relations Tejas Savant will participate in a fireside chat at Citi’s 2025 Global Healthcare Conference. The event is scheduled for 9 to 9:45 a.m. EDT on Thursday, Dec. 4, 2025, in Miami, Florida. A live audio webcast and replay of the presentation will be available through Agilent’s Investor Relations website. About Agilent Tech...
Back to Newsroom